´ëÇÑÇǺθ鿪ÇÐȸ ½ÉÆ÷Áö¾ö : 2022-11-19±³À°ÀÏÀÚ : 2022-11-19
±³À°Àå¼Ò : ¼¿ï »ïÁ¤È£ÅÚ 2Ãþ ¶óº¥´õȦ
±³À°ÁÖÁ¦ :
´ëÇÑÇǺθ鿪ÇÐȸ ½ÉÆ÷Áö¾öÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑÇǺθ鿪ÇÐȸ
´ã´çÀÚ : ÃÖÁ¾¿ø ±³¼ö
¿¬¶ôó : 031-787-7316
À̸ÞÀÏ :
mdcwc@naver.com ±³À°Á¾·ù : ÇǺΰú
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 3 ½Ã°£ 50ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 11-19 ¶óº¥´õȦ 13:30~13:35 Àλ縻 À±»ó¿õ(¼¿ïÀÇ´ë)
±âŸ 11-19 ¶óº¥´õȦ 13:35~13:40 Ãà»ç ±èÀ¯Âù(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 11-19 ¶óº¥´õȦ 13:40~14:03 JAK/STAT in psoriasis (Th1/Th17 cell) Áֹμ÷(ÇѾçÀÇ´ë)
±³À°½Ã°£ 11-19 ¶óº¥´õȦ 14:03~14:26 JAK/STAT in atopic dermatitis (Th2 cell) ½Å±âÇõ(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 11-19 ¶óº¥´õȦ 14:26~14:50 JAK/STAT in alopecia areata and vitiligo (CD8 T cell) ¹ÚÇö¼±(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-19 ¶óº¥´õȦ 14:50~15:20 The interplay between the immune and nervous system ¼ÛÇØÁØ(°í·ÁÀÇ´ë)
ÈÞ½Ä 11-19 15:20~15:40 Coffee break & Group photo ()
±³À°½Ã°£ 11-19 ¶óº¥´õȦ 15:40~16:03 PDE4 inhibitor È«Á¾¼ö(µ¿±¹ÀÇ´ë)
±³À°½Ã°£ 11-19 ¶óº¥´õȦ 16:03~16:26 Tyk2 inhibitor ÃÖÁ¾¿ø(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-19 ¶óº¥´õȦ 16:26~16:50 BTK inhibitor ¹Ú±Í¿µ(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 11-19 ¶óº¥´õȦ 16:50~17:50 Bystander T cells & autoimmunity ÃÖÁ¦¹Î(ÇѾç´ëÇб³ »ý¸í°úÇаú)
±âŸ 11-19 ¶óº¥´õȦ 17:50~18:00 Æóȸ»ç À±»ó¿õ(¼¿ïÀÇ´ë)